Tech Company Financing Transactions
OrganOx Funding Round
OrganOx, operating out of Oxford, England, secured investment capital from Intuitive Venture Partners, Piper Heartland and Terumo.
Transaction Overview
Company Name
Announced On
5/14/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Oxford Science Park Sherrington Building, Magdalen Centre, R
Oxford, England, OX4 4GA
UK
Oxford, England, OX4 4GA
UK
Phone
Website
Email Address
Overview
OrganOx is at the forefront of changing the way donor organs are preserved in the critical time between donation and transplantation. Our leading product, the metra®, harnesses patented normothermic machine perfusion technology to preserve donor livers for up to 24 hours prior to transplant. Our Chief Medical Officer, Professor Peter Friend, and colleagues heralded the start of the normothermic machine perfusion revolution in liver transplantation with a first publication in 2002.2 Since then, over 50 publications have supported the patented OrganOx technology demonstrating its advantages over conventional cold storage and cold perfusion technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Craig Marshall
Chief Financial Officer
Graham Yeatman
Browse more venture capital transactions:
Prev: 5/14/2025: VFlowTech venture capital transaction
Next: 5/14/2025: Layer AI venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs